AOD9604 - 5 MG

AOD9604 is a research peptide based on a small portion of human growth hormone. It is studied to understand whether selected metabolic signals associated with the larger hormone can be examined separately from its broader biological activity.

More specifically, AOD9604 research has focused on lipid metabolism, fat-cell biology, metabolic signaling, and the biological activity of growth-hormone-derived peptide fragments.

Technical Identity: AOD9604 is commonly described as a modified peptide fragment corresponding to the C-terminal region of human growth hormone, rather than the complete growth-hormone molecule.

Azyven Research AOD9604 is supplied exclusively for laboratory research and analytical use.

What is AOD9604?

AOD9604 is a modified peptide based on amino acids 176–191 from the C-terminal region of human growth hormone. Its design allows researchers to examine the biology associated with this specific region without studying intact growth hormone itself.

Why is AOD9604 studied?

AOD9604 has attracted research interest because studies have associated the C-terminal growth-hormone region with aspects of fat metabolism.

Researchers have investigated AOD9604 to better understand lipid breakdown, fat oxidation, energy balance, and whether these processes can be separated from classical growth-hormone receptor signaling.

What research areas are associated with AOD9604?

Lipid-Metabolism Research
AOD9604 has been studied in connection with how biological systems store, mobilize, and metabolize lipids.

Lipolysis Research
Studies have explored processes involved in the release and breakdown of stored fat.

Fat-Oxidation Research
Research has examined AOD9604 in connection with metabolic pathways involved in the use of fatty acids as energy substrates.

Energy-Balance Research
AOD9604 has been investigated as part of broader research into body-weight biology and energy regulation.

Growth-Hormone Fragment Research
Researchers use AOD9604 to investigate how a defined fragment of growth hormone differs biologically from the intact hormone.

What have studies found?

Published studies have explored AOD9604 across lipid-metabolism and body-weight-related research.

Lipid and fat metabolism
Research has reported changes involving lipolysis, fat oxidation, and adipose-tissue metabolism.

Growth-hormone receptor signaling
Studies have found that AOD9604 does not interact with the growth-hormone receptor in the same way as intact growth hormone, supporting research into potentially distinct signaling behavior.

Human research programs
AOD9604 has also been evaluated in human development programs examining metabolic and body-weight-related outcomes.

Evidence context
The research record includes multiple experimental settings, and results from one setting should not automatically be generalized to another.

How does AOD9604 relate to other Azyven products?

AOD9604 approaches metabolic research through a growth-hormone-derived peptide fragment rather than through incretin receptors or GHRH signaling.

Researchers may compare it with Tesamorelin, Sermorelin, or CJC-1295 (No DAC) when examining different parts of growth-hormone biology, or with Azyven's incretin-focused products when comparing distinct metabolic pathways.

Researchers can ask Aria Jr. to explain these differences or compare associated research areas.

What am I purchasing?

Azyven Research AOD9604 is supplied as a lyophilized research material.

Available Strength: 5 mg
Form: Lyophilized powder
Product Type: Research Peptide
Intended Use: Laboratory research only

Research Use Only: Azyven Research products are intended for laboratory research purposes only. They are not intended for human or veterinary use, consumption, administration, or clinical application.